Thermo Fisher Scientific Inc.

TMO Healthcare Diagnostics & Research

Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024.

Revenue
+9.13%
EPS
+8.64%
Free cash flow
+15.0%
Total debt
+22.8%

Quarter to September 2026, against a year earlier

679.52 26.64 −3.77%
Market cap
$250.8B
P/E
35.8×
Fwd P/E
35.7×
Dividend yield
0.27%
F-score
5/9
Altman Z
3.84
Beneish M
−2.46
Dividend safety
88/100

Thermo Fisher Scientific Inc. (TMO) Shares outstanding

Alert me on Shares outstanding

Thermo Fisher Scientific Inc.'s shares outstanding at the end of fiscal 2025 was $378.0M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $371.0M. Over the past ten years it has ranged from $378.0M (fiscal 2025) to $406.0M (fiscal 2018) — the current reading is the lowest in ten years. Thermo Fisher Scientific Inc. ranks 3rd of 49 Diagnostics & Research companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $378.0M (1.31%)
FY2024 $383.0M (1.29%)
FY2023 $388.0M (1.52%)
FY2022 $394.0M (0.76%)
FY2021 $397.0M (0.50%)
FY2020 $399.0M (0.99%)
FY2019 $403.0M (0.74%)
FY2018 $406.0M 2.01%
FY2017 $398.0M 0.25%
FY2016 $397.0M (1.24%)

Quarterly newest first

Period Shares outstanding Change
Sep 2026 $371.0M 0.00%
Jun 2026 $371.0M (0.54%)
Mar 2026 $373.0M (1.32%)
Dec 2025 $378.0M 0.00%
43 more quarters

Against its own ten years

Low $378.0M High $406.0M
Ten-year median $397.0M
Current reading's percentile 9

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on TMO